The Huck Institutes of the Life Sciences

Receptor may be key to treating nonalcoholic fatty liver disease

Inhibiting a nuclear receptor in the gut could lead to a treatment for a liver disorder that affects almost 30 percent of the Western world's adult population, according to an international team of researchers.